Navigation Links
Food and Drug Law Institute Sponsors Major Enforcement Conference
Date:12/20/2007

Top FDA and DOJ Officials, Legal Experts to Discuss Latest Criminal Cases, Decrees and How They Now Apply to Food and Dietary Supplement Industries

WASHINGTON, Dec. 20 /PRNewswire-USNewswire/ -- In the last year, mainstream drug and device companies have agreed to pay more than $1.9 billion in fines, civil settlements and penalties. Top drug company executives have paid multimillion dollar fines even though they did not participate in or know about the crimes.

With the Federal Government increasingly seeking legal action against pharmaceutical and device companies -- even those who didn't intend to do anything wrong -- there's a burgeoning need for food and drug industry stakeholder to stay current with federal enforcement developments.

To help meet those needs, the Food and Drug Law Institute is sponsoring its 6th Annual Conference on Enforcement & Litigation: Consent Decrees, Criminal Cases and Corporate Integrity Agreements, Feb. 19-20 at the L'Enfant Plaza Hotel in Washington, D.C.

At the conference, experts will discuss the latest enforcement actions and litigation and ways that voluntary implementation measures required by corporate integrity agreements and consent decrees can help food, drug and device firms stay clear of expensive and often demoralizing action.

Conferees will hear directly from Food and Drug Administration and Department of Justice officials, including luncheon speaker Gerald R. Masoudi, FDA's Chief Counsel and Eugene Thirolf, Director of DOJ's Office of Consumer Litigation. Other FDA officials include Deborah Autor, Director of Compliance, CDER; Joseph R. Baca, Director of Food Safety, CFSAN; Eric M. Blumberg, Deputy Chief Counsel for Litigation; Garry L. Coody, National Health Fraud Coordinator, Office of Enforcement, ORA; David K. Elder, Director, Office of Enforcement, Office of Regulatory Affairs; Annamarie Kempic, Associate Deputy for Litigation; Mary Anne Malarkey, Director, Office of Compliance & Biologics Quality, CBER; Vernessa T. Pollard, Associate Chief Counsel - Enforcement, OCC; Michael C. Rogers, Director, Office of Field Investigations, Office of Regulatory Affairs; Steven D. Silverman, Assistant Director, Officer of Compliance, CDER; Laura M. Tarentino, Office of Food Additive Safety, CFSAN; and Timothy A. Ulatowski, Director of Compliance, CDRH.

To register for the conference, visit http://www.fdli.org or call (800) 956-6923 or (202) 371-1420.

Founded in 1949, FDLI publishes the award-winning, peer-reviewed Food and Drug Law Journal; the bimonthly magazine Update; FDA Directory; and dozens of books and publications for attorneys, regulatory affairs practitioners, scientists, health care professionals, government employees and marketers in the food and drug field. For more information, visit http://www.fdli.org


'/>"/>
SOURCE Food and Drug Law Institute
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. The Risk Management and Patient Safety Institute Announces Annual Health Care Risk Conference Dates
2. Mayo Clinic Multidisciplinary Simulation Center Receives Distinction as an ACS-Accredited Education Institute
3. LifeNet Health Establishes The Skin & Wound Allograft Institute
4. Statement from Employment Policies Institute on Senator Hillary Clintons Health Care Plan
5. CAS Medical Systems, Inc. Awarded $2.8 Million Grant by National Institutes of Health
6. Portico Systems to Share Provider Network Management Best Practices at Institute for International Research
7. The Integrated Benefits Institute Offers Largest Benchmarking Database in U.S. Spanning Disability and Workers Compensation Programs
8. The Cooper Institutes FITNESSGRAM Selected as Statewide Physical Fitness Assessment Tool
9. Bullying Prevention Institute Designed to Empower Change in Schools
10. Southern Research Institutes Neurodegenerative Disease Drug Discovery Program Receives National Institute of Mental Health Funding
11. Corey McPherson Nash Develops Case Statement for Dana-Farber Cancer Institute Capital Campaign
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/26/2017)... , ... April 26, 2017 , ... ... performance, is proud to announce that it has received 510(k) clearance from the ... MyoCycle Home and the MyoCycle Pro. , Both devices are stationary cycling systems ...
(Date:4/25/2017)... Louisville, KY (PRWEB) , ... April 25, 2017 ... ... to announce they have signed an agreement to be the preferred physical therapy ... with injuries and returning them to Derby City CrossFit as quickly and effectively ...
(Date:4/25/2017)... ... April 25, 2017 , ... As ... decision-makers are preparing for how his administration could impact the employee benefits industry. ... what changes are most likely to make it through Congress. His discussion will ...
(Date:4/25/2017)... ... April 25, 2017 , ... Lake Park Dental is now accepting new ... in Lutz, FL. With the help of this highly-effective, yet convenient system, patients ... complications, more discretion and less pain. , Drs. Sarah Jockin, Nicole Morganti, Sara ...
(Date:4/25/2017)... RESTON, VIRGINIA (PRWEB) , ... April 25, 2017 ... ... scientists leading the way in unveiling cutting-edge birth defects research related to Zika ... recognized by the world’s premier society for this important science. , ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)... April 20, 2017 Research and Markets ... Contract Manufacturing Services Market Analysis By Service (Manufacturing, Research), By ... 2014 - 2025" report to their offering. ... The Latin American pharmaceutical contract ... by 2025 Low drug registration cost in Latin ...
(Date:4/19/2017)... April 19, 2017 The Mobile X-Ray product segment ... healthy CAGR during the forecast period Mobile X-Ray ... global digital mobile X-Ray devices market, which is estimated to ... expanding at a CAGR of 7% over the forecast period. ... of more than US$ 100 Mn in 2017 over 2016. ...
(Date:4/19/2017)... NEW YORK , April 19, 2017 /PRNewswire/ ... This report on the prostate cancer ... of the global market. Increasing prevalence of prostate ... as innovation in the development of new drugs ... hormone-refractory prostate cancer drug due to lesser side ...
Breaking Medicine Technology: